Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119249645 | 11924964 | 5 | F | 20151113 | 20160915 | 20160118 | 20160920 | EXP | US-BAYER-2015-470667 | BAYER | 65.00 | YR | E | M | Y | 0.00000 | 20160920 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119249645 | 11924964 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, BID (200 MG/2 TABS TWICE A DAY | 21923 | 400 | MG | FILM-COATED TABLET | BID | ||||||
| 119249645 | 11924964 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | DOSE DECREASED TO 200 MG, QD | 21923 | 200 | MG | FILM-COATED TABLET | QD | ||||||
| 119249645 | 11924964 | 3 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, BID | 21923 | 400 | MG | FILM-COATED TABLET | BID | ||||||
| 119249645 | 11924964 | 4 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK | 0 | |||||||||||
| 119249645 | 11924964 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | 0 | |||||||||||
| 119249645 | 11924964 | 6 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 119249645 | 11924964 | 7 | C | TRAMADOL HYDROCHLORIDE. | TRAMADOL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 119249645 | 11924964 | 8 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 119249645 | 11924964 | 9 | C | HYDROCHLOROTHIAZIDE W/TRIAMTERENE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119249645 | 11924964 | 1 | Hepatocellular carcinoma |
| 119249645 | 11924964 | 2 | Hepatocellular carcinoma |
| 119249645 | 11924964 | 3 | Hepatocellular carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119249645 | 11924964 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119249645 | 11924964 | Alopecia | |
| 119249645 | 11924964 | Off label use | |
| 119249645 | 11924964 | Palmar erythema | |
| 119249645 | 11924964 | Platelet count decreased | |
| 119249645 | 11924964 | Surgery |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119249645 | 11924964 | 1 | 20151023 | 0 | ||
| 119249645 | 11924964 | 2 | 20151114 | 0 |